Cargando…

Legislative activity related to the human papillomavirus (HPV) vaccine in the United States (2006–2015): a need for evidence-based policy

State-based policies to mandate HPV vaccination are politically challenging and have received broad criticisms. There is a critical need to understand the legislative activities that underpin subsequent policy implementation. The objective of this policy analysis was to analyze state legislation tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Keim-Malpass, Jessica, Mitchell, Emma M, DeGuzman, Pamela B, Stoler, Mark H, Kennedy, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356918/
https://www.ncbi.nlm.nih.gov/pubmed/28331378
http://dx.doi.org/10.2147/RMHP.S128247
_version_ 1782515948229492736
author Keim-Malpass, Jessica
Mitchell, Emma M
DeGuzman, Pamela B
Stoler, Mark H
Kennedy, Christine
author_facet Keim-Malpass, Jessica
Mitchell, Emma M
DeGuzman, Pamela B
Stoler, Mark H
Kennedy, Christine
author_sort Keim-Malpass, Jessica
collection PubMed
description State-based policies to mandate HPV vaccination are politically challenging and have received broad criticisms. There is a critical need to understand the legislative activities that underpin subsequent policy implementation. The objective of this policy analysis was to analyze state legislation that focused on HPV vaccination from 2006–2015. A content analysis was conducted among primary sources of legislative data from HPV vaccine-related bills, including using the National Conference of State Legislatures as a search-source. Findings reveal that much of the legislative activity occurred early after the HPV vaccination was introduced, and focused on increased information for parents, public financing, awareness campaigns, etc. Far fewer states focused on voluntary or mandatory vaccination. Understanding the barriers to achieving mandatory vaccination policy and implementation of such policies for HPV vaccines remains a public health priority.
format Online
Article
Text
id pubmed-5356918
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-53569182017-03-22 Legislative activity related to the human papillomavirus (HPV) vaccine in the United States (2006–2015): a need for evidence-based policy Keim-Malpass, Jessica Mitchell, Emma M DeGuzman, Pamela B Stoler, Mark H Kennedy, Christine Risk Manag Healthc Policy Short Report State-based policies to mandate HPV vaccination are politically challenging and have received broad criticisms. There is a critical need to understand the legislative activities that underpin subsequent policy implementation. The objective of this policy analysis was to analyze state legislation that focused on HPV vaccination from 2006–2015. A content analysis was conducted among primary sources of legislative data from HPV vaccine-related bills, including using the National Conference of State Legislatures as a search-source. Findings reveal that much of the legislative activity occurred early after the HPV vaccination was introduced, and focused on increased information for parents, public financing, awareness campaigns, etc. Far fewer states focused on voluntary or mandatory vaccination. Understanding the barriers to achieving mandatory vaccination policy and implementation of such policies for HPV vaccines remains a public health priority. Dove Medical Press 2017-03-13 /pmc/articles/PMC5356918/ /pubmed/28331378 http://dx.doi.org/10.2147/RMHP.S128247 Text en © 2017 Keim-Malpass et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Short Report
Keim-Malpass, Jessica
Mitchell, Emma M
DeGuzman, Pamela B
Stoler, Mark H
Kennedy, Christine
Legislative activity related to the human papillomavirus (HPV) vaccine in the United States (2006–2015): a need for evidence-based policy
title Legislative activity related to the human papillomavirus (HPV) vaccine in the United States (2006–2015): a need for evidence-based policy
title_full Legislative activity related to the human papillomavirus (HPV) vaccine in the United States (2006–2015): a need for evidence-based policy
title_fullStr Legislative activity related to the human papillomavirus (HPV) vaccine in the United States (2006–2015): a need for evidence-based policy
title_full_unstemmed Legislative activity related to the human papillomavirus (HPV) vaccine in the United States (2006–2015): a need for evidence-based policy
title_short Legislative activity related to the human papillomavirus (HPV) vaccine in the United States (2006–2015): a need for evidence-based policy
title_sort legislative activity related to the human papillomavirus (hpv) vaccine in the united states (2006–2015): a need for evidence-based policy
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356918/
https://www.ncbi.nlm.nih.gov/pubmed/28331378
http://dx.doi.org/10.2147/RMHP.S128247
work_keys_str_mv AT keimmalpassjessica legislativeactivityrelatedtothehumanpapillomavirushpvvaccineintheunitedstates20062015aneedforevidencebasedpolicy
AT mitchellemmam legislativeactivityrelatedtothehumanpapillomavirushpvvaccineintheunitedstates20062015aneedforevidencebasedpolicy
AT deguzmanpamelab legislativeactivityrelatedtothehumanpapillomavirushpvvaccineintheunitedstates20062015aneedforevidencebasedpolicy
AT stolermarkh legislativeactivityrelatedtothehumanpapillomavirushpvvaccineintheunitedstates20062015aneedforevidencebasedpolicy
AT kennedychristine legislativeactivityrelatedtothehumanpapillomavirushpvvaccineintheunitedstates20062015aneedforevidencebasedpolicy